|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
RESEARCH ARTICLE |
Department of Biology, Wesleyan University, Hall-Atwater Labs, Room 257, Lawn Ave, Middletown, CT 06459, USA
*Author for correspondence (e-mail: lgrabel{at}wesleyan.edu)
Accepted March 27, 2001
The integrin ß1 cytoplasmic domain plays a key role in a variety of integrin-mediated events including adhesion, migration and signaling. A number of studies suggest that phosphorylation may modify the functional state of the cytoplasmic domain, but these studies frequently only examine the effect of substituting amino acid mimics that cannot be phosphorylated. We now demonstrate, using site directed mutagenesis, that substituting either an unphosphorylated (S to M) or a phosphorylated (S to D) mimic in place of serine can modify integrin function. Specifically, we show that expressing a residue that mimics a dephosphorylated form of the protein promotes cell spreading and directed cell migration, whereas a residue mimicking a phosphorylated form of the protein promotes attachment but inhibits cell spreading or migration. The significance of these observations is strengthened by the fact that the ß1 mutations display the same properties in both a fibroblast cell line (GD25) and a teratocarcinoma cell line (F9). The results indicate that changes in the phosphorylation state of S785 modulates ß1 integrin function.
Key words: Phosphorylation, ß1 Integrin, Serine, GD25, F9
This article has been cited by other articles:
![]() |
W. J. French, E. E. Creemers, and M. D. Tallquist Platelet-Derived Growth Factor Receptors Direct Vascular Development Independent of Vascular Smooth Muscle Cell Function Mol. Cell. Biol., September 15, 2008; 28(18): 5646 - 5657. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, J. Wang, B. Kinzel, M. Mueller, X. Mao, R. Valdez, Y. Liu, and E. Li Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity Blood, September 1, 2007; 110(5): 1502 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, G. Lian, R. Lenkinski, A. De Grand, R. R. Vaid, T. Bryce, M. Stasenko, A. Boskey, C. Walsh, and V. Sheen Filamin B mutations cause chondrocyte defects in skeletal development Hum. Mol. Genet., July 15, 2007; 16(14): 1661 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Dandapani, H. Sugimoto, B. D. Matthews, R. J. Kolb, S. Sinha, R. E. Gerszten, J. Zhou, D. E. Ingber, R. Kalluri, and M. R. Pollak {alpha}-Actinin-4 Is Required for Normal Podocyte Adhesion J. Biol. Chem., January 5, 2007; 282(1): 467 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Banu, J. Teichman, M. Dunlap-Brown, G. Villegas, and A. Tufro Semaphorin 3C regulates endothelial cell function by increasing integrin activity FASEB J, October 1, 2006; 20(12): 2150 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sato, T. Yamochi, T. Yamochi, U. Aytac, K. Ohnuma, K. S. McKee, C. Morimoto, and N. H. Dang CD26 Regulates p38 Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Integrin {beta}1, Adhesion to Extracellular Matrix, and Tumorigenicity of T-Anaplastic Large Cell Lymphoma Karpas 299 Cancer Res., August 1, 2005; 65(15): 6950 - 6956. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pankov, E. Cukierman, K. Clark, K. Matsumoto, C. Hahn, B. Poulin, and K. M. Yamada Specific beta 1 Integrin Site Selectively Regulates Akt/Protein Kinase B Signaling via Local Activation of Protein Phosphatase 2A J. Biol. Chem., May 9, 2003; 278(20): 18671 - 18681. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Hilden, L. Valmu, S. Karkkainen, and C. G. Gahmberg Threonine Phosphorylation Sites in the {beta}2 and {beta}7 Leukocyte Integrin Polypeptides J. Immunol., April 15, 2003; 170(8): 4170 - 4177. [Abstract] [Full Text] [PDF] |
||||